Literature DB >> 12923572

The structure of bovine F1-ATPase in complex with its regulatory protein IF1.

Elena Cabezón1, Martin G Montgomery, Andrew G W Leslie, John E Walker.   

Abstract

In mitochondria, the hydrolytic activity of ATP synthase is prevented by an inhibitor protein, IF1. The active bovine protein (84 amino acids) is an alpha-helical dimer with monomers associated via an antiparallel alpha-helical coiled coil composed of residues 49-81. The N-terminal inhibitory sequences in the active dimer bind to two F1-ATPases in the presence of ATP. In the crystal structure of the F1-IF1 complex at 2.8 A resolution, residues 1-37 of IF1 bind in the alpha(DP)-beta(DP) interface of F1-ATPase, and also contact the central gamma subunit. The inhibitor opens the catalytic interface between the alpha(DP) and beta(DP) subunits relative to previous structures. The presence of ATP in the catalytic site of the beta(DP) subunit implies that the inhibited state represents a pre-hydrolysis step on the catalytic pathway of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923572     DOI: 10.1038/nsb966

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  78 in total

1.  Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.

Authors:  Laura Sánchez-Cenizo; Laura Formentini; Marcos Aldea; Alvaro D Ortega; Paula García-Huerta; María Sánchez-Aragó; José M Cuezva
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Structure of the mitochondrial ATP synthase by electron cryomicroscopy.

Authors:  John L Rubinstein; John E Walker; Richard Henderson
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

3.  Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability.

Authors:  Makoto Fujikawa; Hiromi Imamura; Junji Nakamura; Masasuke Yoshida
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

4.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 5.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 6.  Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor.

Authors:  Pierre Vantourout; Claudia Radojkovic; Laeticia Lichtenstein; Véronique Pons; Eric Champagne; Laurent O Martinez
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

7.  The shrimp mitochondrial FoF1-ATPase inhibitory factor 1 (IF1).

Authors:  Cindy Chimeo; Analia Veronica Fernandez-Gimenez; Michelangelo Campanella; Ofelia Mendez-Romero; Adriana Muhlia-Almazan
Journal:  J Bioenerg Biomembr       Date:  2015-08-25       Impact factor: 2.945

8.  Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease.

Authors:  Moon-Yong Cha; Hyun Jin Cho; Chaeyoung Kim; Yang Ouk Jung; Min Jueng Kang; Melissa E Murray; Hyun Seok Hong; Young-Joo Choi; Heesun Choi; Dong Kyu Kim; Hyunjung Choi; Jisoo Kim; Dennis W Dickson; Hyun Kyu Song; Jin Won Cho; Eugene C Yi; Jungsu Kim; Seok Min Jin; Inhee Mook-Jung
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

9.  Inhibitory and anchoring domains in the ATPase inhibitor protein IF1 of bovine heart mitochondrial ATP synthase.

Authors:  Franco Zanotti; Gabriella Raho; Antonio Gaballo; Sergio Papa
Journal:  J Bioenerg Biomembr       Date:  2004-10       Impact factor: 2.945

Review 10.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.